Industry

1BoringOldMan picks up where he left off two years ago - critiquing Robert Gibbons' misuse of statistical analysis to claim that antidepressants were both...

In the business of clinical trials, the most valuable commodities are the research subjects. Filling clinical trials is hard, and filling them quickly is even harder. That’s why in 2000 a clinical investigator told the HHS Office of the Inspector General that research sponsors were looking for three things from research sites: “No. 1—rapid enrollment. No. 2 — rapid enrollment. No. 3 — rapid enrollment.”

Keris Myrick, MIA blogger and, as of today, the former chair of the board of the National Alliance for Mental Illness, will be the...

In a review of the evidence regarding benzodiazepines, researchers from the University of Michigan find that benzodiazepines used in the treatment of PTSD are...

Senator Charles Grassley (R-Iowa) "inappropriate prescriptions." Finds "shocking" that medicaid prescribers write "more prescriptions than seems humanly possible." Read more            ...

From the Center for Health Journalism: Due to drug safety scandals and rising drug prices, pharmaceutical representatives are increasingly being criticized by physicians, medical schools, and...

From STAT: Despite evidence that drug company sales reps skew prescribing habits, relatively few hospitals have taken the step of barring them. This is a...

From HealthNewsReview.org: The Alliance for Patient Access (AfPA), a nonprofit organization that claims to advocate for patients to have access to FDA-approved treatments, has consistently worked...

Legislation in the U.K. that empowers psychiatrists to impose treatment  on patients has lost the support of one of its key advocates. "The evidence is...

Part of the case against GlaxoSmithKline settled yesterday involved the company's use of paid experts to promote non-FDA approved uses of its drugs. One...

The U.N. special rapporteur on torture has opened discussions with the U.S. mission in Geneva as a first step toward investigating the Judge Rotenberg...

The latest in a series of Zoloft-related birth defect lawsuits was filed in St. Louis yesterday, by a firm that claims to represent hundreds...

Stimulant medications like Ritalin and Adderall, often prescribed to treat children diagnosed with ADHD, are known to cause hallucinations and psychotic symptoms. Until recently these adverse effects were considered to be rare. A new study to be published in the January issue of Pediatrics challenges this belief, however, and finds that many more children may be experiencing psychotic symptoms as a result of these drugs than previously acknowledged.

In this piece for the BMJ, Jeanne Lenzer profiles Vikas Saini, a cardiologist who is working to fight against excessive medical treatment. His work with...

In this editorial for Tidsskriftet, Ketil Slagstad discusses how the Norwegian media's uncritical coverage of the Lancet antidepressant study points to deeper underlying issues within the...

A new study has found that of 10 people who were fully recovered from their first episode of schizophrenia (FES), those not taking antipsychotics did better in terms of cognitive, social, and role functioning—and reached full recovery more quickly.

From STAT: “Imagine that someone offers to give you a guard dog. When the wretched creature arrives, you find out that she is calf-high,...

From HealthNewsReview.org: While researchers are usually required to disclose their conflicts of interest in medical journals, media outlets do not often require journalists to disclose...

Review of pediatric antidepressant studies finds the vast majority are negative on primary outcomes and an increased risk for suicidality.

It is "unethical" for the British government to establish expected rates of depression and to pay doctors per diagnosis to increase the diagnosing of...

A study from Lisa Cosgrove at Harvard's Safra Center for Ethics of potential conflicts of interest among DSM-5 committee members, investigators of new DSM-5 diagnoses,...

Research published in the Journal of Clinical Psychiatry shows that of all 901 patients diagnosed with schizophrenia from July 2009 to June 2010 at a...

The Seventh Circuit Court of Appeals yesterday rejected a lower court's dismissal of  Watson v. King-Vassel, saying that a jury is in fact sufficiently able...

Despite concerns about the risk to benefit ratio, the FDA approved flibanserin (Addyi) to treat low female sexual desire in August. In a new...

From STAT: A small biotech company, AveXis, recently offered a $3,000 honorarium along with paid airfare and lodging to several experts to attend a so-called...